Max P. Benzaquen, MD
Neurology Physician · Chesterfield, MO
Max P. Benzaquen, MD is a neurology physician with a practice address in Chesterfield, Missouri, and NPI 1366426900, issued on Dec 6, 2005. Check the license (Missouri 100507, as entered in NPPES) on the Missouri Board of Registration for the Healing Arts; the Medicare figures below come from public CMS files.
- Name
- Max P. Benzaquen
- Credential
- MD
- Primary taxonomy
- Neurology Physician 2084N0400X
- License number
- 100507 MO
Self-reported in NPPES; status is on the state search - Practice location
- 14377 Woodlake Dr Ste 308, Chesterfield, MO 63017
- Phone
- (314) 878-8744
- Enumerated
- Dec 6, 2005
- Record last updated
- Jun 19, 2025
- Fax
- (314) 878-2234
- Entity
- Type 1 · individual
8 nearest neurology physician records → All 484 in Missouri → Look up another NPI →
Verify Max P. Benzaquen in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMissouri Board of Registration for the Healing Arts
Search for license 100507Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
3.7 times the Medicare Part D claims of the average neurology physician in 2024
5,046 Medicare Part D claims for 498 beneficiaries, against an average of 1,370 among the 15,005 providers of this specialty who prescribed in Part D. Brand-name drugs were 9% of claims. 190 claims were for opioids.
Most prescribed
- Carbidopa-Levodopa289 claims
- Duloxetine Hcl211 claims
- Memantine Hcl Er182 claims
- Clonazepam176 claims
- Gabapentin173 claims
- Pramipexole Dihydrochloride151 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 0 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $8,059.41
394 payments; by number, the most common kind was food and beverage; the largest payer was Jazz Pharmaceuticals Inc. The 10,858 providers of this specialty with any payment received $8,318.07 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Max P. Benzaquen among 484 neurology physician records in Missouri
Max P. Benzaquen, MD is one of 484 neurology physician records with a practice address in Missouri. 78% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2005, is newer than 0% of them.
- NPI issued2005 · 0% of these records are older, 95% newer
- In a Medicare fileYes · 78% of these records are
- In the CMS Doctors and Clinicians fileNo · 59% of these records are
- Record last updated2025 · 36% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 2084N0400X and a Missouri practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Neurology Physician providers in Missouri
There are 484 neurology physician records in Missouri.
All 484 in Missouri → Every provider in Chesterfield → Neurology Physician nationwide →
The 8 neurology physician records with the nearest ZIP codes
- Zaheer Ahmed, M.D.Chesterfield, MO 630171558328401
- Leah Brancheck, M.D.Chesterfield, MO 630171255747119
- Frasat Chaudhry, M.D.Chesterfield, MO 630171073772604
- Ayman DaoudChesterfield, MO 630171487013512
- Emily Evans, MDChesterfield, MO 630171710326939
- Susan Lippmann, M.D.Chesterfield, MO 630171295857936
- Patti Nemeth, M.D.Chesterfield, MO 630171144284225
- Daniel Phillips, M.D.Chesterfield, MO 630171497813976
Common questions
What is Max P. Benzaquen, MD's NPI number?
Max P. Benzaquen, MD's National Provider Identifier (NPI) is 1366426900, issued on Dec 6, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Max P. Benzaquen, MD located?
The NPPES record lists a practice address at 14377 Woodlake Dr Ste 308, Chesterfield, MO, 63017. Phone: (314) 878-8744. Providers update this record themselves, so call before visiting.
How can I verify Max P. Benzaquen, MD's license?
NPPES lists Missouri license number 100507, as entered by the provider. Search the Missouri Board of Registration for the Healing Arts at https://www.fsmb.org/contact-a-state-medical-board/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Max P. Benzaquen, MD prescribe under Medicare Part D?
In 2024, Max P. Benzaquen, MD had 5,046 Medicare Part D claims for 498 beneficiaries; the average among neurology physician prescribers was 1,370. Part D covers Medicare prescriptions only.
What is Max P. Benzaquen, MD's MIPS final score?
The 2023 MIPS final score is 0 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.